T1	HMM 0 24	Effectiveness and Safety
T2	HMM 268 298	effectiveness and tolerability
T3	HMM 706 732	decrease in pain intensity
T4	HMM 737 759	average pain intensity
T5	HMM 946 962	(n = 288), the
T6	HMM 1072 1088	on the change in
T7	HMM 1200 1220	for noninferiority).
T8	HMM 1221 1257	Neuropathic pain and quality-of-life
T9	HMM 1276 1304	significantly in both groups
T10	HMM 1574 1603	of the composite of dizziness
T11	HMM 1763 1840	associated with comparable improvements in pain intensity and quality-of-life
T12	HMM 1867 1924	300 mg/pregabalin 300 mg, with improved central nervous
